After refuting a supposed data leak as 'falsified', Olema reveals first clinical data for lead program — shares crash

Max Gelman

Senior Editor

Olema Oncology had been preparing to present the first clinical data from its lead program at a conference next week, but the biotech’s poster supposedly …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

After refuting a supposed data leak as 'falsified', Olema reveals first clinical data for lead program — shares crash

Max Gelman

Senior Editor

Sign up to read this article for free.

Pfizer wants in on Summit’s goal to beat Keytruda via ADC combos

Pfizer hires ex-FDA deputy Patrizia Cavazzoni as chief medical officer

Post-Hoc: Pharma CEOs' alternative reality with Trump

Sanofi, Teva bolster case for IBD drug with Phase 2 data, despite potential competition

FDA approves first drug to treat ultra-rare lipid storage disease

How AI can address ongoing challenges in the life sciences industry

Af­ter re­fut­ing a sup­posed da­ta leak as 'fal­si­fied', Ole­ma re­veals first clin­i­cal da­ta for lead pro­gram — shares crash

Max Gelman

Senior Editor

Sign up to read this article for free.

Pfiz­er wants in on Sum­mit’s goal to beat Keytru­da via ADC com­bos

Pfiz­er hires ex-FDA deputy Pa­trizia Cavaz­zoni as chief med­ical of­fi­cer

Post-Hoc: Phar­ma CEOs' al­ter­na­tive re­al­i­ty with Trump

Sanofi, Te­va bol­ster case for IBD drug with Phase 2 da­ta, de­spite po­ten­tial com­pe­ti­tion

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

After refuting a supposed data leak as 'falsified', Olema reveals first clinical data for lead program — shares crash

Pfizer wants in on Summit’s goal to beat Keytruda via ADC combos

Pfizer hires ex-FDA deputy Patrizia Cavazzoni as chief medical officer

Post-Hoc: Pharma CEOs' alternative reality with Trump

Sanofi, Teva bolster case for IBD drug with Phase 2 data, despite potential competition

FDA approves first drug to treat ultra-rare lipid storage disease

How AI can address ongoing challenges in the life sciences industry